The goal of this study was to identify genes that are differentially expressed between ccRCC and normal tissue, to group them according to their function (pathway analysis) and to validate a number of potential biomarkers in a homogenous patient group, well defined with respect to VHL, HIF1A, EPAS1 expression and clinical parameters. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.